Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
, and society. We're proud of our strong reputation in molecular biology and biotechnology, but even more of the people behind it. Currently, we are looking for a Learning & Development manager Do you
-
medical development are welcome and we might actually recruit two persons with complementary expertise. Additional information may be found in the following selected references: De Strooper, B. & Karran, E
-
developing genetic risk scores as biomarkers for neurological disorders. The Rademakers lab leads cutting-edge research into risk genes and molecular mechanisms in Frontotemporal Dementia (FTD), while
-
diverse classes of inhibitory neurons are specified and integrated into brain circuits during development. Our work bridges developmental neurobiology, disease modeling, and systems neuroscience. To do
-
Postdoctoral position to study species-specific mechanisms of gene regulation in human neurons. The Vanderhaeghen Lab (https://pvdhlab.org ) and the Aerts Lab (www.aertslab.org ) at VIB KULeuven are seeking creative postdoctoral scientists to study the human-specific mechanisms of gene...
-
in healthy states, genetically perturbed states, and during liver regeneration. On the other hand, you will develop algorithms to disentangle direct intercellular signals from those that are induced
-
and Saeys teams. In this research project you will develop and apply algorithms to link clinical phenotypes of metastasis to molecular phenotypes in mouse models. It is known that metastases exhibit
-
and Delivery: Design and develop training programs on Data Science and AI topics, including machine learning algorithms, data visualization, and statistical analysis. Provide foundational sessions about
-
human-specific features of brain development influence early cortical circuit function and the pathophysiology of autism spectrum disorders (ASD) Research Project “Linking human-specific synaptic
-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We